Prevalence of adverse events in clinical trials involving filgrastim as documented by clinicaltrials.gov identifiers.

Each bar shows the percentage of individuals that experienced the adverse events broken down by sub-adverse events for each clinical trial denoted by ClinicalTrials.gov. The colours show details about adverse events categories. (EPS)